PEOPLE - AtriCure makes appointment
This article was originally published in Clinica
AtriCure, a manufacturer of cardiac ablation systems, based in West Chester, Ohio, has appointed veteran life sciences executive Mark Collar to its board of directors. Mr Collar is chairman of Ohio's $1.6bn fund for high-tech research, innovation and company formation (the Third Frontier Advisory Board) and vice-chairman and member of the executive committee of BioOhio, which promotes the growth of local life-science companies. He joins from Procter & Gamble, where he was president of the global pharmaceuticals division.
You may also be interested in...
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.